PUBLICATIONS

Original Articles

AW Harris, A Douds, EV Meurisse, S Chambers, SR Gould
High seroprevalence of Helicobacter pylori in residents of a hospital for people with severe learning difficulties.
Eur J Gastroenterol Hepatol 1995; 7: 21-3

AW Harris, PA Gummett, RPH Logan, HA Ashworth, JJ Misiewicz, JH Baron
Eradication of Helicobacter pylori with lansoprazole and clarithromycin.
Aliment Pharmacol Ther 1995; 9: 201-4

AW Harris, MM Walker, A Smolka, JM Waller, JH Baron, JJ Misiewicz
Prevalence of parietal cells in the duodenal bulb & relationship to H pylori infection.
Journal of Clinical Pathology 1996; 49: 309-12

AW Harris, PA Gummett, JJ Misiewicz, JH Baron
Eradication of Helicobacter pylori lowers acid output in patients with duodenal ulcer.
Gut 1996; 38: 663-7

AW Harris, MM Walker, JM Waller, JH Baron, JJ Misiewicz
The relationship between duodenal gastric metaplasia, acid output and H pylori.
Gut 1996; 39: 513-20

AW Harris, DI Pryce, SM Gabe, et al.
Lansoprazole, clarithromycin & metronidazole for one week cures H pylori infection.
Aliment Pharmacol Ther 1996; 10 (6): 1005-8

AW Harris, PA Gummett, P Phull, MR Jacyna, JJ Misiewicz, JH Baron
Recurrence of duodenal ulcer after H pylori eradication is related to high acid output.
Aliment Pharmacol Ther 1997; 11: 331-4

JJ Misiewicz, AW Harris, KD Bardham, et al.
One week triple therapy for Helicobacter pylori: a multi-centre comparative study.
Gut 1997; 41: 735-9

AW Harris, JJ Misiewicz, KD Bardham et al.
Incidence of duodenal ulcer healing after one week of PPI triple therapy for eradication of Helicobacter pylori.
Aliment Pharmacol Ther 1998; 12 (8): 741-5

P Moayyedi, on behalf of the Dyspepsia Review Group (includes AW Harris)
Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia.
BMJ 2000; 321: 659-64

MR Fox, AW Harris
An assessment of open access referral for PEG in a district general hospital.
Eur J Gastroenterol Hepatol 2002; 14 (11): 1245-9

P Moayyedi, S Soo, J Deeks, D Forman, AW Harris, M Innes, B Delaney
Systematic review: antacids H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia.
Aliment Pharmacol Ther 2003: 17: 1215-27

BH Hayee, AW Harris
Methotrexate for Crohn's disease: experience in a district general hospital.
Eur J Gastroenterol Hepatol 2005; 17 (9): 893-8

KM Taylor, K Arajs, T Rouse, AW Harris
Prospective audit of colonoscopy quality in Kent and Medway, UK.
Endoscopy 2008; 40: 1-4

EA Russo, AW Harris, S Campbell, et al.
Experience of maintenance infliximab therapy for refractory ulcerative colitis in England.
Aliment Pharmacol Ther 2009; 29: 308-14

EA Russo, M Iacucci, JO Lindsay, S Campbell, AL Hart, J Hamlin, J Orchard, N Arebi, J Nightingale, MR Jacyna, SM Gabe, M O'Connor, AW Harris, C O'Morain, S Ghosh
Survey regarding the use of adalimumab as maintenance therapy in Crohn's disease in England and Ireland.
Eur J Gastro Hepatol 2010; 22 (3): 334-9

DE Loft, AW Harris, IG Barrison
Revalidation of Gastroenterologists, with or with out sedation!
Frontline Gastroenterology 2010; 1: 70-5

I Coltart, L Blackmore, C Caisley, AW Harris
Parenteral methotrexate for patients with Crohn's Disease: how to develop a high-quality and safe self-administration service.
Frontline Gastroenterology 2012; 3: 36-8

L Blackmore, AW Harris
A prospective study of infliximab withdrawal after 12 months of treatment in patients with Crohn's disease: how will NICE guidance affect patient care?
Clinical Medicine 2012; 12 (3): 235-8

NICE Clinical Guideline on the Management of Ulcerative Colitis (June 2013)
http://guidance.nice.org.uk/cg166

GSZ Tun, AW Harris, AJ Lobo
Ulcerative colitis: Management in adults, children, and young people – concise guidance.
Clinical Medicine 2017; 17 (5): 1-5


Reviews, Leading Articles and Letters in Learned Journals

AW Harris, JJ Misiewicz
Hitting H. pylori for four.
Lancet 1995; 345: 806-7

AW Harris
Helicobacter pylori testing at home.
Eur J Gastroenterol Hepatol 1995; 7: 595-6

AW Harris, JJ Misiewicz
Treating Helicobacter pylori - the best is yet to come?
Gut 1996; 39 (6): 781-3

AW Harris
Helicobacter pylori and urea breath testing. Can the breath test result predict the outcome of treatment?
Italian Journal of Gastroenterology and Hepatology 1998; 30: 151-2

AW Harris
Current regimens for treatment of Helicobacter pylori.
In: MJG Farthing and SE Patchett, eds. British Medical Bulletin: Helicobacter infection
1998; 54 (1): 195-205

AW Harris
Understanding Inflammatory Bowel Disease.
In: CR-ROM 'Inflammatory Bowel Diseases' S Schreiber et al. Walter de Gruyter GmbH, Berlin, 1998

AW Harris
Drugs, Diseases and Disorders: Pentasa in ulcerative colitis.
NHS Doctor and Commissioning GP Summer 1998: 57-8

AW Harris
Inflammatory bowel disease: safety of current therapies.
Hospital Update Supplement August 1998: 9-10

AW Harris
Treatment of H pylori.
World Journal of Gastroenterology 2001; 7 (3): 303-7

AW Harris, JJ Misiewicz
Management of Helicobacter pylori infection.
British Medical Journal 2001; 323: 1047-50

BH Hayee, AW Harris
6-mercaptopurine and mesalasine for prevention of relapse after conservative surgery for Crohn's disease.
Gastroenterology 2005; 128(1): 249

G Sisson, AW Harris
Certolizumab Pegol for treatment of Crohn's disease.
Gastroenterology 2006; 130(1): 285-6

K Taylor, AW Harris
Ulcerative Colitis: an overview.
Chemist and Druggist 5 May 2007: 34-8

AW Harris
Gastroenterology in 2050.
Hospital Doctor June 2007

KM Taylor, AW Harris
Extent of colonoscopy.
Gastroenterology 2007; 133: 1391-2


Books

AW Harris, JJ Misiewicz
Clinician's Manual on Helicobacter pylori
Science Press Limited, London, 1995 (Second edition 1997).

AW Harris, JJ Misiewicz
Helicobacter pylori.
Blackwell Scientific Publications Limited, Oxford, 1996.

AW Harris, JJ Misiewicz
Lecture notes on Helicobacter pylori.
Rapid Science Press Limited, London, 1996.

AW Harris
CD-ROM: Peptic ulcer disease.
RSM Press, London, 1998

JH Baron, R Logan, AW Harris, JJ Misiewicz (eds.)
ABC of Upper Gastrointestinal Tract.
BMJ, London, 2002 (ISBN 0-7279-1266-6)

AW Harris
Handbook of Gastrointestinal Emergencies.
Science Press Limited, London 2002 (ISBN 1-85873-394-4)

AW Harris
Starting Out in Private Practice. 

In: British Society of Gastroenterology Handbook for Private Practice, London 2010


Recent Abstracts at National or International Gastroenterology Meetings

LP Maiden, GJ Lawson, AW Harris
Development of human anti-murine antibodies in patients following treatment with infliximab.
Gut 2003; 52 (Suppl 1): A62

LP Maiden, AW Harris
Parenteral methotrexate in refractory Crohn's disease: experience in a district general hospital.
Gut 2003; 53 (Suppl 1): A63

BH Hayee, M Barnden, AW Harris
Waiting list validation for screening and surveillance colonoscopy.
Gut 2005; 54 (Suppl 11): A74

BH Hayee, S Basavarajaiah, AW Harris
Guided primary care management of inflammatory bowel disease.
Gut 2005; 54 (Suppl 11): A107

AW Harris, K Arajs, T Rouse
Prospective audit of colonoscopy quality in Kent & Medway.
Gut 2006; 55 (Suppl 11): A8

G Sisson, AW Harris
Is conscious sedation practiced safely in patients undergoing colonoscopy.
Gut 2006; 55 (Suppl 11): A 94

S McLaughlin, AW Harris
Audit of 30 day mortality following PEG insertion in a District General Hospital compared with NCEPOD results.
Gut 2007; 56 (Suppl 1): fA95

T Demetriou, C Gawad, C Kok, AW Harris
Two year prospective audit of use of liquid diets as "bridge" therapy for active Crohn's disease.
Gut 2008; 57 (Suppl 1): A18

KM Taylor, AW Harris
Infliximab as a treatment for ulcerative colitis: 3 years experience in a district general hospital.
Gut 2008; 57 (Suppl 1): A149

KM Taylor, GJ Lawson, AW Harris
Cardiac troponins in patients treated with biological therapy for inflammatory bowel disease.
Journal of Crohn's & Colitis 2009; 3 (1): S59

KM Taylor, H Sharma, B Nedjat-Shokouhi, GL Bird, AW Harris
Retrospective study of outcomes of patients with Crohn's disease treated with early immunosuppression.
Journal of Crohn's & Colitis 2009; 3 (1): S66

KM Taylor, AW Harris
Parenteral methotrexate for Crohn's disease: 9 years experience in a district general hospital.
Journal of Crohn's & Colitis 2009; 3 (1): S85

PA Blaker, B Nedjat-Shokouhi, DM Thomas, AW Harris
Myenteric plexitis does not predict endoscopic Crohn's disease recurrence 12 months following ileo-colonic resection in district general hospital practice.
Gut 2009; 58 (Suppl 1): A98

EA Russo, JJ Lindsay, S Campbell, LA Hart, PJ Hamlin, TR Orchard, N Arebi, J Nightingale, MR Jacyna, M O'Connor, AW Harris, CA O'Morain, S Ghosh
Experience on the use of adalimumab as maintenance therapy in Crohn's disease.
Gut 2009; 58 (Suppl 1): A61

BD Warner, L Blackmore, C Mungalsingh, AW Harris
A prospective audit of the use of calcineurin inhibitors in patients with refractory ulcerative procto-colitis in a district general hospital.
Gut 2012; 61 (Suppl 2): A169

AS Dhillon, AW Harris
A prospective audit of the use of tacrolimus in patients with refractory subacute ulcerative colitis in a district general hospital.
Gut 2014; 63 (Suppl 1): A63

BS Kailey, PA Blaker, L Macken, D Rajashekar, AW Harris

Optimising Crohn's disease treatment based on the Rutgeerts' score 12 months after ileo-colic resection.

Gut 2015; 64 (Suppl 1): A93

L Macken, A Dhillon, AW Harris

Five year prospective study of the use of tacrolimus in patients with refractory subacute ulcerative colitis.

Gut 2015; 64 (Suppl 1): A236